Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France.

Compared to beta-blocker users, AED users were more likely to switch back to the branded drug, whereas this difference was not observed with neuroleptics. These results could reflect a poor acceptance of switching AEDs to generic compounds in France.